Skip to Main Content

Evaluate the Safety and Efficacy of FG-3019 in Patients With Idiopathic Pulmonary Fibrosis


Diseases of the Digestive System - Small Intestines, Large Intestines & Rectum

Phase III

What is the purpose of this trial?

Yale is participating in this phase III research study that is testing a new stem cell therapy treatment for perianal fistulas with Crohn’s Disease.

You may qualify if:

  • You are between the ages of 18 to 75
  • Have been diagnosed with Crohn’s Disease for at least 6 months
  • Are not having symptoms of Crohn’s Disease but have perianal fistula(s) that have not responded to treatment
  • Trial with
    TiGenix S.A.U.
  • Start Date
  • End Date

I'm interested in volunteering

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email or call 877.978.8343

  • Last Updated
  • Study HIC